Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
Thrombotic complications from COVID-19 are now well known and contribute to significant morbidity and mortality. Different variants confer varying risks of thrombotic complications. Heparin has anti-inflammatory and antiviral effects. Due to its non-anticoagulant effects, escalated-dose anticoagulat...
Main Authors: | Mandeep Singh Rahi, Jay Parekh, Prachi Pednekar, Mayuri Mudgal, Vishal Jindal, Kulothungan Gunasekaran |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2038-8330/15/2/37 |
Similar Items
-
A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
by: Dimitrios Velissaris, et al.
Published: (2023-04-01) -
COVID-19 and anticoagulant based therapeutics: Approach with great promise
by: Varun Kumar Sharma, et al.
Published: (2021-05-01) -
Anticoagulant Therapy in Moderate to Severe COVID-19 Patients
by: Agus Fitriyanto Achmad, et al.
Published: (2022-01-01) -
The Role of Factor Xa-Independent Pathway and Anticoagulant Therapies in Cancer-Related Stroke
by: Hyung Jun Kim, et al.
Published: (2021-12-01) -
Spontaneous Breast Haematoma after Heparin Anticoagulation
by: Imran Yaseen Gani, et al.
Published: (2020-06-01)